
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **PTN (Pleiotrophin)**: Involved in cell growth and angiogenesis.<br>- **MGP (Matrix Gla Protein)**: Inhibits vascular calcification.<br>- **CCL28 (C-C Motif Chemokine Ligand 28)**: Involved in immune response, particularly in mucosal tissues.<br>- **SYNM (Synemin)**: Intermediate filament protein, associated with cytoskeletal structure.<br>- **LTF (Lactotransferrin)**: Involved in immune response and iron binding.<br>- **SFRP1 (Secreted Frizzled-Related Protein 1)**: Modulates Wnt signaling pathway.<br>- **MMP7 (Matrix Metallopeptidase 7)**: Involved in extracellular matrix remodeling.<br>- **NDRG2 (N-Myc Downstream Regulated 2)**: Associated with stress response and cell differentiation.<br>- **CRYAB (Alpha-Crystallin B Chain)**: Functions as a molecular chaperone.<br>- **SLPI (Secretory Leukocyte Peptidase Inhibitor)**: Inhibits proteases and has antimicrobial properties.<br>- **ANXA1 (Annexin A1)**: Involved in anti-inflammatory responses.<br>- **WEE1 (WEE1 G2 Checkpoint Kinase)**: Regulates cell cycle progression.<br>- **ATF3 (Activating Transcription Factor 3)**: Involved in stress response.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT15 (Keratin 15)**: Marker for epithelial stem cells, particularly in the basal layer of the epidermis.<br>- **SCGB2A2 (Secretoglobin Family 2A Member 2)**: Highly expressed in mammary gland epithelial cells.<br>- **SCGB2A1 (Secretoglobin Family 2A Member 1)**: Also associated with mammary gland epithelial cells.<br>- **KRT14 (Keratin 14)**: Basal epithelial cell marker, often found in stratified epithelia.<br>- **KRT17 (Keratin 17)**: Associated with basal/myoepithelial cells in the mammary gland.<br>- **KRT7 (Keratin 7)**: Expressed in simple epithelia and some glandular tissues.<br>- **CLDN4 (Claudin 4)**: Tight junction protein, expressed in epithelial cells.<br>- **TACSTD2 (Tumor-Associated Calcium Signal Transducer 2)**: Expressed in epithelial cells, including those in the mammary gland.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast tissue and cancer, the markers SCGB2A2, SCGB2A1, KRT14, KRT17, and KRT7 are strongly associated with epithelial cells, particularly those in the mammary gland. SCGB2A2 and SCGB2A1 are specific to secretory epithelial cells in the breast.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of markers such as SCGB2A2, SCGB2A1, KRT14, KRT17, and KRT7, the most probable general cell type is **epithelial cells**. These markers are indicative of cells involved in the structure and function of the mammary gland epithelium.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: SCGB2A2 and SCGB2A1 are highly specific to luminal epithelial cells in the mammary gland.<br>2. **Basal/Myoepithelial Cells**: KRT14 and KRT17 are markers for basal/myoepithelial cells, which are supportive and contractile cells in the mammary gland.<br>3. **Ductal Epithelial Cells**: KRT7 and CLDN4 are expressed in ductal epithelial cells, which line the ducts of the mammary gland.<br><br>The most likely subtype based on the markers is **Luminal Epithelial Cells**, given the high expression of SCGB2A2 and SCGB2A1.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is primarily composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the high expression of SCGB2A2 and SCGB2A1, which are characteristic of luminal epithelial cells in the mammary gland. Other markers such as KRT14 and KRT17 indicate the presence of basal/myoepithelial cells, while KRT7 and CLDN4 suggest ductal epithelial cell involvement. However, the predominant expression pattern aligns with luminal epithelial cells.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers SCGB2A2, SCGB2A1, KRT14, KRT17, and KRT7, which are crucial for identifying epithelial cells, particularly in the mammary gland, are included in the marker list.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation acknowledges the presence of multiple subtypes within the epithelial cell category, such as luminal epithelial cells, basal/myoepithelial cells, and ductal epithelial cells. <br>   - The analysis correctly identifies luminal epithelial cells as the predominant subtype based on the high expression of SCGB2A2 and SCGB2A1, while also noting the presence of markers for other epithelial subtypes.<br><br>The annotation process has been thorough, cross-referencing known databases and literature to support the identification of the cell type and its subtypes. The conclusion aligns well with the expression patterns of the markers provided.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Basal/Myoepithelial Cells</li><li>Ductal Epithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a thorough and methodical approach to identifying the cell types present in the single-cell dataset derived from human breast cancer tissue. The analysis effectively utilizes a comprehensive list of markers, considering both functional and cell type-specific markers, to arrive at a well-supported conclusion.<br><br>1. **Correctness of Annotations**: The annotations are scientifically accurate. The identification of epithelial cells, particularly luminal epithelial cells, is well-supported by the presence of key markers such as SCGB2A2 and SCGB2A1, which are highly specific to luminal epithelial cells in the mammary gland. The inclusion of other markers like KRT14 and KRT17 further supports the presence of basal/myoepithelial cells, while KRT7 and CLDN4 suggest ductal epithelial cells. This multi-faceted approach ensures that the annotation captures the complexity of the cell population.<br><br>2. **Balanced Consideration of Multiple Markers**: The analysis does not overly focus on a single marker but rather considers a range of markers to provide a balanced view of the cell types present. The use of both functional markers (e.g., PTN, MGP) and cell type markers (e.g., KRT15, SCGB2A2) demonstrates a comprehensive approach to annotation. The consideration of marker rank, with more emphasis on those appearing earlier in the list, is appropriately handled.<br><br>3. **Comprehensive View of Cell Types**: The annotation provides a comprehensive view of the cell types present, acknowledging the presence of multiple epithelial subtypes. The identification of luminal epithelial cells as the predominant subtype is well-justified, and the analysis also recognizes the potential presence of basal/myoepithelial and ductal epithelial cells, which adds depth to the understanding of the cell population.<br><br>4. **Consideration of Marker Rank**: The analysis appropriately considers the rank of the markers, giving more weight to those appearing earlier in the list, such as PTN and MGP, which are involved in key biological processes relevant to the tissue context.<br><br>Overall, the annotation is well-executed, scientifically sound, and provides a clear and comprehensive picture of the cell populations present in the dataset. There are no obvious misclassifications or oversights, and the analysis effectively balances the use of different markers to support its conclusions.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    